Wilmington, Delaware, United States, Transparency Market Research Inc. – Blood transfusion diagnostics are products used to conduct tests before transfusion of blood and blood products from donor to recipient.
Wilmington, Delaware, United States, Transparency Market Research Inc. – Blood transfusion diagnostics are products used to conduct tests before transfusion of blood and blood products from donor to recipient. These products include instruments such as analyzers and centrifuges, and kits & reagents for various tests such as blood grouping and disease screening for donors as well as patients. Blood screening is a major step in the pre-transfusion process.
Read Report Overview - https://www.transparencymarketresearch.com/blood-transfusion-market.html
Various instruments, test kits, and reagents based on molecular and serological techniques are used to detect transfusion transmitted infections (TTIs) along with establishing the compatibility of donor and patient blood group before transfusion. The global blood transfusion diagnostics market was valued at US$ 3.0 Bn in 2016 and is projected to expand at a CAGR of 5.9% from 2017 to 2025 to reach US$ 5.5 Bn by 2025.
Increase in shift toward automation in blood banks is likely to benefit blood collection facilities due to reduced turnaround time for test completion and overcoming the shortage of workforce required to conduct the requisite tests.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23963
Deployment of automated systems is anticipated to help these facilities to reorganize workflow and increase efficiency. Rise in demand for blood and blood components transfusions owing to large patient population suffering from chronic diseases such as aplastic anemia, sickle cell anemia, and leukemia is the major factor driving the blood transfusion diagnostics market.
According to estimates provided by the American Cancer Society, nearly 62,130 new cases of leukemia were reported in the U.S. alone in 2017. According to Centers for Disease Control and Prevention (CDC) estimates, 100,000 people are affected by sickle cell disease in the U.S. each year. Rise in incidence of chronic diseases presents large patient population requiring blood transfusions. This is expected to drive demand for blood transfusions, leading to increase in demand for transfusion diagnostic instruments, kits, and reagents.
There is a shift toward automation of instruments, multiplexing assays, and new techniques for blood grouping and disease screening, delivering high throughput results with reduced turnaround time, and enabling health care providers to analyze multiple samples in short time. In February 2017, Immucor, Inc. announced the launch of MIA FORA NGS FLEX HLA Typing Assay, a new molecular test for blood typing. Increase in government initiatives and implementation of policies regarding blood safety and availability are anticipated to drive demand and consumption of blood transfusion diagnostic test instruments and kits, which in turn is likely to propel the market during the forecast period.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=23963
In September 2017, the Ministry of Health of Saudi Arabia launched a national campaign named My Blood for My Country along with various protocols for blood transfusion diagnostics in the country. However, shortage of highly skilled technologists for blood transfusion services and decline in blood donation rates across the globe are likely to hamper the growth of the market. Nevertheless, burgeoning needs of blood banks for plasma testing of recovered plasma for infectious disease screening offers significant opportunity for players operating in the global blood transfusion diagnostic market for developing new tests and assays for plasma testing.
The global blood transfusion diagnostics market has been segmented based on product type, application, end-user, and region. In terms of product type, the kits & reagents segment is anticipated to account for major market share, followed by the instruments segment. Increase in blood donations and rise in number of blood transfusion procedures globally are factors contributing to the high consumption of kits & reagents for blood transfusion diagnostics. Based on application, the disease screening segment accounted for the largest market share in 2016 and is expected to gain market share by 2025. Increase in emphasis on disease screening tests owing to rise in incidence of transfusion transmitted infections is likely to augment the segment from 2017 to 2025. In terms of end-user, the blood banks segment held the dominant share in terms of revenue in 2016. The segment is projected to maintain its lead over the other segments during the forecast period. Increase in number of blood banks and blood centers globally is expected to fuel the growth of the market.
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=23963
Geographically, North America was the leading market in terms of revenue due to high percentage of active and voluntary blood donors in countries such as the U.S. and Canada, increase in number of blood transfusions per year, and various blood transfusion policies being implemented regarding safety and testing of blood for infectious diseases. The market in Asia Pacific is projected to grow at a rapid pace during the forecast period, owing to large patient pool requiring blood transfusions and rise in awareness about disease screening in countries in the region.
Major players in the global blood transfusion diagnostics market include BAG Health Care GmbH, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Grifols, S.A., Immucor, Inc., Hologic, Inc., Ortho Clinical Diagnostics, and Quotient Limited.
Rising Demand for Donor Screening Motivates Growth in Blood Transfusion Diagnostics Market
Increasing prevalence of chronic diseases as well as the rising demand for donor screening are couple of most prominent factors influencing growth in the global blood transfusion diagnostics market. Increase in the prevalence of various chronic diseases, including anemia, hemophilia, liver disease, sickle cell disease, thrombocytopenia, cancer, kidney diseases, and severe infections have all led to increased demand in the global blood transfusion diagnostics market. Among these, anemia, one of the most common blood disorders is caused by deficiency of iron in human blood. This requires transfusion of red blood cells, hence leading to an increased demand for products in the global blood transfusion diagnostics market.
Furthermore, rising awareness regarding the blood transfusion diagnosis in order to prevent hazardous blood borne diseases and infection, as well as fast paced shift toward automation and mechanization of blood and blood component storage banks are stimulating the growth trajectory in global blood transfusion diagnostics market. The pandemic situation created by the outbreak of novel corona virus has also presented the global blood transfusion diagnostics market with numerous growth opportunities. For example, there were multiple plasma transfusion trials conducted in the United States.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=23963
However, the pandemic also created certain challenges for the global blood transfusion diagnostics market. Some of the key challenges faced by the players in global blood transfusion diagnostics market over the pandemic include diminished donor inflow, shortage of blood units, rising concerns pertaining to transfusion transmitted corona virus, and dearth of skilled professional staff. However, since the debarring of social restrictions, there has been considerable increase in the blood transfusion and blood donation procedures all over the world. This trend is favoring the development of the global blood transfusion diagnostics market.
Shift of various industry players towards Molecular Automated Platforms is also another significant driver for the global blood transfusion diagnostics market in recent times. Introduction of these automated molecular platforms is bolstering the shift from manual instruments and tests towards semi as well as fully automated testing instruments. This has resulted in fast detection of transfusion transmissible infections as well as in eliminating human error during transfusion procedures.
More Trending Reports by Transparency Market Research –
Medical Waste Management Market: The global medical waste management market is expected to reach the value of US$ 25.2 Bn by the end of 2028.
Bioprocess Technology Market: The global bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031.
Cell Culture Media, Sera, and Reagents Market: The global cell culture media, sera, and reagents market is expected to reach the value at US$ 18.3 Bn by the end of 2031.
Cell Culture Market: The global cell culture market is expected to reach the value of US$ 27.6 Bn by the end of 2031. It is estimated to expand at a CAGR of 9% from 2021 to 2031.
Contraceptives Market: The global contraceptives market is expected to cross the value of US$ 2.7 Bn by the end of 2028.
Human Microbiome Market: The global human microbiome market is expected to reach the value of US$ 2.2 Bn by the end of 2028.
Molecular Diagnostics Market: The global molecular diagnostics market is expected to reach the value of US$ 37.19 Bn by the end of 2028.
Mice Model Market: The global mice model market is expected to reach the value of US$ 2.3 Bn by the end of 2028. It is estimated to expand at a CAGR of 6.2% from 2021 to 2028.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com